NAD+ Supplements for Men 40+

This report synthesizes current human clinical data on NAD+ precursors tailored for men over 40. While preclinical data is robust, human evidence is emerging and highly specific.

Effective at Boosting NAD+

Oral supplementation with NR and NMN consistently raises blood NAD+ levels in men aged 40+, typically doubling levels within 2-4 weeks.

Metabolic Focus

Strongest clinical signals for Men 40+ are in metabolic health (insulin sensitivity), particularly for those overweight or pre-diabetic.

Safety Profile

Studies up to 1 year show excellent safety for doses up to 1g/day. Main concerns are cost, product purity, and regulatory status.

Why Supplement? The NAD+ Decline

"By age 50, NAD+ levels in tissue can drop by ~50% compared to age 20. This decline correlates with mitochondrial dysfunction and metabolic stress."

Bottom Line

Supplementation restores levels to youthful baselines, but the clinical focus is on health-span, not just numbers.

The Molecule Landscape

Comparing the primary precursors available on the market.

Evidence Dashboard

Interactive analysis of clinical outcomes. Select a domain to see the strength of evidence.

Metabolic Health

Evidence Grade:MODERATE

Clinical Summary

Strongest signal for NAD+ boosters. NMN has demonstrated improved muscle insulin sensitivity in pre-diabetic women. Data for healthy, non-obese men is less compelling but suggests preventative value.

Key Peer-Reviewed Studies

  • Yoshino et al. (Science, 2021): NMN (250mg) increased muscle insulin sensitivity in prediabetic women.
  • Dollerup et al. (2018): NR (2g) did not improve insulin sensitivity in obese men, suggesting ceiling effects.
  • Igarashi et al. (2022): NMN reduced arterial stiffness in middle-aged adults with high BMI.
60%Signal Rate
Positive
Neutral
Inconcl.

Protocol & Safety

Practical guidance based on current clinical practices.

Clinical Dose Estimator

Drag the slider to visualize expected outcomes and economic impact of NR/NMN supplementation.

NoneLowStandardHigh

Low Dose Entry

250-300mg

Standard entry dose used in early safety trials. Sufficient to raise blood NAD+ by ~40-50%. Good starting point for preventative support.

Est. Cost$40-60 / mo
Risk ProfileVery Low

Safety & Precautions

Active Cancer

Theoretical risk that NAD+ fuels tumor growth. Avoid supplementation if undergoing active cancer treatment unless specifically cleared by oncology.

Methylation Balance

High dose NR/NMN may deplete methyl groups (homocysteine rise). Experts suggest adding TMG to support the methylation cycle during high-dose protocols.

Circadian Optimization

Take in the morning. NAD+ synthesis follows circadian rhythms (SIRT1 is clock-regulated). Late-day dosing may disrupt normal sleep architecture.

"Always source from batches tested for purity (>99%) and stabilized for shelf life, as NAD+ precursors can degrade rapidly."

The Bottom Line for Men 40+

NAD+ supplementation is scientifically promising but not a magic bullet. It is most likely to benefit men with existing metabolic strain (overweight, pre-diabetic) or older adults (>60). For fit, healthy men in their 40s, effects may be subtle or preventative.

Top Pick (Evidence)NR or NMN (500mg)
Top Pick (Value)Niacin (Low Dose)